EMA Authorised: Lamzede (velmanase alfa) — Chiesi Farmaceutici S.p.A.

View source ↗

Summary

The European Medicines Agency authorised Lamzede (velmanase alfa) by Chiesi Farmaceutici S.p.A. for the treatment of alpha-mannosidosis, with orphan medicine de…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-mannosidosis

Drugs mentioned

• Lamzede (velmanase alfa)

Snippet

Status: Authorised. Therapeutic area: alpha-Mannosidosis. MAH: Chiesi Farmaceutici S.p.A.. Decision date: 02/03/2026. Orphan medicine